TY - JOUR
T1 - Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships
T2 - MRI-based study
AU - Popovtzer, Aron
AU - Cao, Yue
AU - Feng, Felix Y.
AU - Eisbruch, Avraham
N1 - Funding Information:
Supported by NIH Grant PO1 CA59827. Presented in part at the 50th Annual Meeting of ASTRO, Boston, MA, September 21–25, 2008.
PY - 2009/12
Y1 - 2009/12
N2 - Purpose: Dysfunction of pharyngeal constrictors (PCs) after chemo-irradiation of head and neck (HN) cancer has been proposed as major cause of dysphagia. We conducted prospective MRI study to evaluate anatomical changes in the PCs after chemo-irradiation, to gain insight of the mechanism of their dysfunction and their dose-effect relationships. The PCs were compared to the sternocleidomastoid muscles (SCMs), which receive high doses but do not relate to swallowing. Patients and methods: Twelve patients with stage III-IV HN cancer underwent MRI before and 3 months after completing chemo-irradiation. T1- and T2-weighted signals and muscle thickness were evaluated for PCs (superior, middle, and inferior), and SCMs. Mean muscle doses were determined after registration with the planning CT. Results: T1-weighted signals decreased in both PCs and SCMs receiving >50 Gy (p < 0.03), but not in muscles receiving lower doses. T2-weighted signals in the PCs increased significantly as the dose increased (R2 = 0.34, p = 0.01). The T2 signal changes in the PCs were significantly higher than the T2 changes in the SCMs (p < 0.001). Increased thickness was noted in all PCs, with muscles receiving >50 Gy gaining significantly more thickness than PCs receiving lesser doses (p = 0.02). In contrast, the SCM thickness decreased post-therapy (p = 0.002). Conclusions: These MRI-based findings, notably the differences between PCs and SCMs, suggest that underlying causes of PC dysfunction are inflammation and edema, likely consequential to acute mucositis affecting the submucosa-lying PCs. These results support reducing mean PC doses to ≤50 Gy, as well as reducing acute mucositis, to improve long-term dysphagia.
AB - Purpose: Dysfunction of pharyngeal constrictors (PCs) after chemo-irradiation of head and neck (HN) cancer has been proposed as major cause of dysphagia. We conducted prospective MRI study to evaluate anatomical changes in the PCs after chemo-irradiation, to gain insight of the mechanism of their dysfunction and their dose-effect relationships. The PCs were compared to the sternocleidomastoid muscles (SCMs), which receive high doses but do not relate to swallowing. Patients and methods: Twelve patients with stage III-IV HN cancer underwent MRI before and 3 months after completing chemo-irradiation. T1- and T2-weighted signals and muscle thickness were evaluated for PCs (superior, middle, and inferior), and SCMs. Mean muscle doses were determined after registration with the planning CT. Results: T1-weighted signals decreased in both PCs and SCMs receiving >50 Gy (p < 0.03), but not in muscles receiving lower doses. T2-weighted signals in the PCs increased significantly as the dose increased (R2 = 0.34, p = 0.01). The T2 signal changes in the PCs were significantly higher than the T2 changes in the SCMs (p < 0.001). Increased thickness was noted in all PCs, with muscles receiving >50 Gy gaining significantly more thickness than PCs receiving lesser doses (p = 0.02). In contrast, the SCM thickness decreased post-therapy (p = 0.002). Conclusions: These MRI-based findings, notably the differences between PCs and SCMs, suggest that underlying causes of PC dysfunction are inflammation and edema, likely consequential to acute mucositis affecting the submucosa-lying PCs. These results support reducing mean PC doses to ≤50 Gy, as well as reducing acute mucositis, to improve long-term dysphagia.
KW - Dysphagia
KW - Head and neck cancer
KW - Pharyngeal constrictors
KW - Radiotherapy
KW - Swallowing
UR - http://www.scopus.com/inward/record.url?scp=70449625641&partnerID=8YFLogxK
U2 - 10.1016/j.radonc.2009.05.013
DO - 10.1016/j.radonc.2009.05.013
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 19520446
AN - SCOPUS:70449625641
VL - 93
SP - 510
EP - 515
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
SN - 0167-8140
IS - 3
ER -